Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Zhengming Jin
CONTACT
Changju Qu
CONTACT
Lead
The First Affiliated Hospital of Soochow University
The study will start with an initial 21-days of induction therapy with orelabrutinib and rituximab,following imaging examinations to evaluate response rates. Then treatment with 6 cycles chemoimmunotherapy (R-CHOP-like) either alone or in combination with orelabrutinib will depend on response during induction phase. Each cycle is 21 days.
Age
18–70
Sex
ALL
Healthy volunteers
Not accepted
